6-Hydroxydopamine induces mitochondrial ERK activation

被引:81
作者
Kulich, Scott M.
Horbinski, Craig
Patel, Manisha
Chu, Charleen T.
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol, Div Neuropathol, Pittsburgh, PA 15261 USA
[2] VA Pittsburgh Healthcare Syst, Dept Pathol, Pittsburgh, PA 15240 USA
[3] Univ Colorado, Dept Pharmaceut Sci, Denver, CO 80262 USA
基金
美国国家卫生研究院;
关键词
mitochondria; reactive oxygen species; Parkinson's disease; extracellular signal-regulated MAP kinases; 6-hydroxydopamine;
D O I
10.1016/j.freeradbiomed.2007.04.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reactive oxygen species (ROS) are implicated in 6-hydroxydopamine (6-OHDA) injury to catecholammergic neurons; however, the mechanism(s) are unclear. In addition to ROS generated during autoxidation, 6-OHDA may initiate secondary cellular sources of ROS that contribute to toxicity. Using a neuronal cell line, we found that catalytic metalloporphyrin antioxidants conferred protection if added 1 h after exposure to 6-OHDA, whereas the hydrogen peroxide scavenger catalase failed to protect if added more than 15 min after 6-OHDA. There was a temporal correspondence between loss of protection and loss of the ability of the antioxidant to inhibit 6-OHDA-induced ERK phosphorylation. Time course studies of aconitase inactivation, an indicator of intracellular superoxide, and MitoSOX red, a mitochondria targeted ROS indicator, demonstrate early intracellular ROS followed by a delayed phase of mitochondrial ROS production, associated with phosphorylation of a mitochondrial pool of ERK. Furthermore, on initiation of mitochondrial ROS and ERK activation, 6-OHDA-injured cells became refractory to rescue by metalloporphyrin antioxidants. Together with previous studies showing that inhibition of the ERK pathway confers protection from 6-OHDA toxicity, and that phosphorylated ERK accumulates in mitochondria of degenerating human Parkinson's disease neurons, these studies implicate mitochondrial ERK activation in Parkinsonian oxidative neuronal injury. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:372 / 383
页数:12
相关论文
共 81 条
[1]   Parkinsonism genes: culprits and clues [J].
Abeliovich, Asa ;
Beal, M. Flint .
JOURNAL OF NEUROCHEMISTRY, 2006, 99 (04) :1062-1072
[2]   Expanding insights of mitochondrial dysfunction in Parkinson's disease [J].
Abou-Sleiman, PM ;
Muqit, MMK ;
Wood, NW .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (03) :207-219
[3]  
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[4]   Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development [J].
Alonso, M ;
Melani, M ;
Converso, D ;
Jaitovich, A ;
Paz, C ;
Carreras, MC ;
Medina, JH ;
Poderoso, JJ .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (01) :248-256
[5]   THE DETERMINATION OF HYDROXYDOPAMINES AND OTHER TRACE AMINES IN THE URINE OF PARKINSONIAN-PATIENTS AND NORMAL CONTROLS [J].
ANDREW, R ;
WATSON, DG ;
BEST, SA ;
MIDGLEY, JM ;
WENLONG, H ;
PETTY, RKH .
NEUROCHEMICAL RESEARCH, 1993, 18 (11) :1175-1177
[6]   Estimation of H2O2 gradients across biomembranes [J].
Antunes, F ;
Cadenas, E .
FEBS LETTERS, 2000, 475 (02) :121-126
[7]   Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice [J].
Asanuma, M ;
Hirata, H ;
Cadet, JL .
NEUROSCIENCE, 1998, 85 (03) :907-917
[8]   Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease [J].
Berman, SB ;
Hastings, TG .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) :1127-1137
[9]  
Betarbet R, 2002, BRAIN PATHOL, V12, P499
[10]   Localization of LRRK2 to membranous and vesicular structures in mammalian brain [J].
Biskup, Saskia ;
Moore, Darren J. ;
Celsi, Fulvio ;
Higashi, Shinji ;
West, Andrew B. ;
Andrabi, Shaida A. ;
Kurkinen, Kaisa ;
Yu, Seong-Woon ;
Savitt, Joseph M. ;
Waldvogel, Henry J. ;
Faull, Richard L. M. ;
Emson, Piers C. ;
Torp, Reldun ;
Ottersen, Ole P. ;
Dawson, Ted M. ;
Dawson, Valina L. .
ANNALS OF NEUROLOGY, 2006, 60 (05) :557-569